Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Allergan (Respiratory Business)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of respiratory drugs. The business develops drugs such as Tudorza Pressair and Daliresp to treat chronic obstructive pulmonary disease.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Parsippany-Troy Hills, NJ
  • United States

Allergan (Respiratory Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Allergan (Respiratory Business)‘s full profile, request access.

Request full access to PitchBook

Allergan (Respiratory Business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Allergan (Respiratory Business)‘s full profile, request access.

Request full access to PitchBook